News for '-divis-laboratories'

Persistent CEO Sandeep Kalra Tops India Inc Salary Charts

Persistent CEO Sandeep Kalra Tops India Inc Salary Charts

Rediff.com2 Sep 2025

BSE 200 companies together paid 5,819.75 crore as remuneration to their CEOs and directors in FY25, up from 5,352.8 crore a year earlier.

Growth and margin uptick critical for gains in Divi's Laboratories

Growth and margin uptick critical for gains in Divi's Laboratories

Rediff.com17 Nov 2023

Rise in input costs, inventory write-off, and pricing pressures led to a drop in gross margins. Higher competitive pressures led to cuts in operating profit margins and earnings estimates for FY24 and FY25. Most brokerages have a 'neutral' or a 'reduce' rating on the stock on account of valuations.

Adani Ports to enter Sensex from June 24; Wipro to move out

Adani Ports to enter Sensex from June 24; Wipro to move out

Rediff.com24 May 2024

Gautam Adani-owned Adani Ports and Special Economic Zone (APSEZ) will replace IT major Wipro in the 30-share BSE Sensex from June 24, according to an official announcement on Friday. This marks the first inclusion of any Adani Group firm in Sensex. The group has 10 listed firms with a combined market valuation surpassing Rs 17 lakh crore.

Nifty may sport new look after Sebi's F&O tweak, expand to over 200 firms

Nifty may sport new look after Sebi's F&O tweak, expand to over 200 firms

Rediff.com6 Jul 2024

The Nifty 50 index is poised for a revamp as the revised futures and options (F&O) stock selection criteria is seen paving the way for newly listed companies to join the benchmark index, which is tracked by passive funds with combined assets under management of more than ~3.5 trillion ($44 billion). For the first time in six years, the market regulator Securities and Exchange Board of India (Sebi) has tweaked the stock selection process for the derivatives segment that clocks a turnover of ~400 trillion daily.

10 Stocks That Soared While Market Sank

10 Stocks That Soared While Market Sank

Rediff.com24 Mar 2025

The stocks are largely from sectors such as chemicals, finance and cement, which struggled earlier but the worse seems to be behind them.

This Tata Stock Has Outperformed Sensex

This Tata Stock Has Outperformed Sensex

Rediff.com27 Sep 2024

In calendar year 2024, the stock price of Trent has zoomed 160% As compared to the 18% rally in the BSE Sensex during the same period. It has outperformed the market in the past 10 consecutive years.

How companies show electoral donations in annual reports

How companies show electoral donations in annual reports

Rediff.com20 Mar 2024

A reading of the reports suggests that there is no standard practice for reporting political contributions and it is left to the company's discretion to report them as they find fit.

Ram temple opening: Ambanis, Bachchan among state guests

Ram temple opening: Ambanis, Bachchan among state guests

Rediff.com19 Jan 2024

While about 8,000 people are in the long list of invitees, the select list features just a few hundred people, including prominent politicians, leading industrialists, top film stars, sportspersons, bureaucrats and diplomats.

Electoral Bonds: The Quid Pro Quo Factor

Electoral Bonds: The Quid Pro Quo Factor

Rediff.com3 Apr 2024

Which entrepreneur would willingly part with her or his hard-earned money for grasping, self-serving politicians? asks Debashis Basu.

Are Markets In An Oversold Zone?

Are Markets In An Oversold Zone?

Rediff.com8 Nov 2023

'Focus on 19,400/64,900 as the key resistance levels for the Nifty/Sensex.'

60% of top 500 stocks achieved their 12-month price target set by analysts

60% of top 500 stocks achieved their 12-month price target set by analysts

Rediff.com17 Oct 2023

As many as 267 of 453 companies from the BSE500 index are trading above their consensus price targets, according to the data compiled by Bloomberg. Not all companies in the BSE500 index are tracked by analysts.

Should you opt to buy stocks of Divis Labs?

Should you opt to buy stocks of Divis Labs?

Rediff.com21 Apr 2023

The stock of Divis Laboratories is up 10 per cent over the last couple of trading sessions on expectations that the worst is behind and the company could see a sequential growth in the March quarter of the 2022-23 financial year (Q4FY23). The stock witnessed the highest downgrades among Nifty50 index stocks with earnings cuts over a third after the Q3FY23 results. The company had posted a 32 per cent drop in revenues over the year ago quarter in Q3FY23 and 8 per cent sequentially, which was sharply lower than Street expectations.

Divi's Labs spurts

Divi's Labs spurts

Rediff.com12 Mar 2003

There was considerable interest in Divi's Laboratories on listing on Wednesday as the scrip turned out at Rs 155, above the issue price of Rs 140.

India business to put a spring in pharma's step

India business to put a spring in pharma's step

Rediff.com26 Apr 2023

Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.

Want To Know What A CEO/MD Earns?

Want To Know What A CEO/MD Earns?

Rediff.com28 Dec 2022

The average top executive monthly compensation is Rs 1 crore. The median employee salary is now Rs 820,000.

Family-owned companies weathering Covid-19 pandemic storm better

Family-owned companies weathering Covid-19 pandemic storm better

Rediff.com10 Sep 2020

Such businesses outperform non-family firms by 3% in first six months of CY20, says Credit Suisse report.

ASK AJIT: Stocks To Buy, Hold, Sell

ASK AJIT: Stocks To Buy, Hold, Sell

Rediff.com11 Mar 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.

Stocks You Must AVOID or EXIT

Stocks You Must AVOID or EXIT

Rediff.com26 Apr 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Sensex, Nifty lose their way, end on a negative note

Sensex, Nifty lose their way, end on a negative note

Rediff.com2 Nov 2017

A widening probe by US authorities involving top drug companies following complaints of price fixing of generics was a point of worry for the participants, said analysts.

'Bought at 21, now at 49. Hold or sell?'

'Bought at 21, now at 49. Hold or sell?'

Rediff.com31 Mar 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Mid-, small-cap stocks on a roll but experts see bubble ahead

Mid-, small-cap stocks on a roll but experts see bubble ahead

Rediff.com23 Aug 2016

market rally, especially in mid-caps, has also been driven by a pick-up in the monsoon and the government's resolve to get the goods and services tax (GST) Bill cleared in the recent session of Parliament.

New dividend tax to hurt Premji, Mukesh Ambani the most

New dividend tax to hurt Premji, Mukesh Ambani the most

Rediff.com2 Mar 2016

Additional levy to eat into Rs 6,000-crore income of top promoters

How India's pharma growth story fizzled out

How India's pharma growth story fizzled out

Rediff.com5 Jul 2017

Once tipped to emerge as the biggest exporter, the pharmaceutical industry is yet to acquire the scale of those in software services, says Krishna Kant.

6 ways to make a fortune when stocks crash

6 ways to make a fortune when stocks crash

Rediff.com7 Aug 2017

Experts suggest six ways to play stocks that tank suddenly and make money as Sanjay Kumar Singh listens in